» Articles » PMID: 8259801

The Risk of Measles, Mumps, and Varicella Among Young Adults: a Serosurvey of US Navy and Marine Corps Recruits

Overview
Specialty Public Health
Date 1993 Dec 1
PMID 8259801
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To assess the risk of epidemic transmission and to guide immunization policy, the seroprevalence of antibody to measles, mumps, and varicella was determined in a group of young adults.

Methods: A cross-sectional study of 1533 US Navy and Marine Corps recruits was conducted in June 1989. Antibody status was determined with commercially available enzyme-linked immunosorbent assays.

Results: Direct sex and race adjustment to the 15- to 29-year-old US population resulted in seronegativity rates of 17.8% for measles, 12.3% for mumps, and 6.7% for varicella. Measles and mumps seronegativity rates were higher among Whites whereas varicella seronegativity was higher among non-Whites. Recruits enlisting from outside the 50 US states, especially those from island territories, were more likely to lack varicella antibody. The sensitivity of a positive history of vaccination or disease in predicting antibody status was less than 90% for all diseases.

Conclusions: These results suggest a continued potential for epidemics, especially of measles, and the need for mandatory immunization policies. Immigrants to the United States, especially those from island territories, may be a high-risk group that could benefit from varicella vaccination.

Citing Articles

Validity of medical record documented varicella-zoster virus among unvaccinated cohorts.

Mohanty S, Perella D, Jumaan A, Robinson D, Forke C, Schmid D Hum Vaccin Immunother. 2013; 9(8):1735-8.

PMID: 23807363 PMC: 3906274. DOI: 10.4161/hv.24849.


Varicella susceptibility in a Canadian population.

Ratnam S Can J Infect Dis. 2007; 11(5):249-53.

PMID: 18159297 PMC: 2094775. DOI: 10.1155/2000/243163.


Varicella seroprevalence and molecular epidemiology of varicella-zoster virus in Argentina, 2002.

Dayan G, Panero M, Debbag R, Urquiza A, Molina M, Prieto S J Clin Microbiol. 2004; 42(12):5698-704.

PMID: 15583301 PMC: 535276. DOI: 10.1128/JCM.42.12.5698-5704.2004.


Postherpetic neuralgia in the cancer patient.

Lojeski E, Stevens R Curr Rev Pain. 2000; 4(3):219-26.

PMID: 10998737 DOI: 10.1007/s11916-000-0083-6.


Varicella vaccine in pregnancy.

Seidman D, Stevenson D, Arvin A BMJ. 1996; 313(7059):701-2.

PMID: 8819427 PMC: 2352106. DOI: 10.1136/bmj.313.7059.701.

References
1.
Shehab Z, Brunell P, Cobb E . Epidemiological standardization of a test for susceptibility to mumps. J Infect Dis. 1984; 149(5):810-2. DOI: 10.1093/infdis/149.5.810. View

2.
LaRussa P, Steinberg S, Waithe E, Hanna B, Holzman R . Comparison of five assays for antibody to varicella-zoster virus and the fluorescent-antibody-to-membrane-antigen test. J Clin Microbiol. 1987; 25(11):2059-62. PMC: 269411. DOI: 10.1128/jcm.25.11.2059-2062.1987. View

3.
Nassar N, Touma H . Brief report: susceptibility of Filipino nurses to the varicella-zoster virus. Infect Control. 1986; 7(2):71-2. DOI: 10.1017/s019594170006392x. View

4.
Gray G, Palinkas L, Kelley P . Increasing incidence of varicella hospitalizations in United States Army and Navy personnel: are today's teenagers more susceptible? Should recruits be vaccinated?. Pediatrics. 1990; 86(6):867-73. View

5.
Neumann P, Weber J, Jessamine A, OShaughnessy M . Comparison of measles antihemolysin test, enzyme-linked immunosorbent assay, and hemagglutination inhibition test with neutralization test for determination of immune status. J Clin Microbiol. 1985; 22(2):296-8. PMC: 268379. DOI: 10.1128/jcm.22.2.296-298.1985. View